Related Experiment Video
Updated: May 27, 2026

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
Engineering of β-glucosidase for rare ginsenoside biosynthesis via distal conformational fine-tuning and sequential
Kun Jiang1, Mengfei Long1, Dongming Sun1
1College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Abstract:
The structural complexity and regiospecificity of ginsenosides pose significant challenges for precise biocatalysis, necessitating enzymes with finely tuned conformational control. Here, we report the high-level biomanufacturing of the rare ginsenoside F2 via computational redesign of β-glucosidase BglPp from Paenibacillus phyllosphaerae. By integrating evolutionary fitness landscapes with thermodynamic stability gradients, we identified a synergistic double mutant, Q7D/G189A, with catalytic efficiency 2.3-fold that of the wild type, achieving an unprecedented F2 titer of 18.01 g/L in a 5-L bioreactor. Mechanistic analyses revealed that distal mutations induce long-range allosteric effects, remodeling the active site and converting substrate binding from nonspecific hydrophobic interactions to a precise "molecular tweezers" mode, stabilized by an enhanced hydrogen-bond network that lowers the activation energy for glycosidic cleavage. Moreover, we uncovered a sequential degradation mechanism governing regioselectivity, which constrains substrate rotational freedom and directs an orderly conversion from ginsenoside Rb1 to F2 by partitioning catalytic trajectories. This work establishes a robust platform for industrial-scale synthesis of rare ginsenosides and provides a generalizable framework for rational engineering of complex carbohydrate-active enzymes in synthetic biology.
Related Concept Videos
Bioreactor Controls-III
Production of Pharmaceuticals
